Comparative Study Between Biodentine and Mineral Trioxide Aggregate in Direct Pulp Capping

NCT02803528 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Patients With Deep Carious Lesions

Interventions

DRUG: Biodentine
DRUG: MTA

Sponsor

Damascus University